DNASE1L3 and systemic lupus erythematosus: Given that about 36%–60% of lupus patients develop significant hypercholesterolemia,26 our findings suggest a possible fourth mechanism for the decreased serum DNase activity in a subset of these patients, namely, a hypercholesterolemia‐induced absolute decrease in the systemic levels of DNase1 and DNase1L3.